
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.92 | 0.92 | 0.00 |
Shares | 99.08 | 99.08 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.24 | 19.94 |
Price to Book | 4.03 | 3.91 |
Price to Sales | 2.25 | 2.27 |
Price to Cash Flow | 14.67 | 15.34 |
Dividend Yield | 1.94 | 1.44 |
5 Years Earnings Growth | 9.81 | 10.93 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.62 | 94.46 |
Basic Materials | 0.31 | 1.90 |
Consumer Defensive | 0.04 | 3.33 |
Financial Services | 0.03 | 8.05 |
Number of long holdings: 182
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 775.45 | -2.47% | |
UnitedHealth | US91324P1021 | 6.48 | 309.11 | +2.14% | |
J&J | US4781601046 | 5.38 | 152.39 | +0.25% | |
AbbVie | US00287Y1091 | 4.91 | 182.38 | -2.36% | |
Roche Holding Participation | CH0012032048 | 3.15 | 261.60 | -0.19% | |
Abbott Labs | US0028241000 | 3.08 | 134.38 | +0.53% | |
Merck&Co | US58933Y1055 | 3.04 | 79.10 | +0.34% | |
Novartis | CH0012005267 | 2.97 | 96.18 | +0.17% | |
Novo Nordisk B | DK0062498333 | 2.92 | 437.5 | +1.53% | |
AstraZeneca | GB0009895292 | 2.55 | 10,224.0 | +0.79% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust F Acc | 532.68K | -6.94 | 11.55 | 13.45 | ||
Legal General US Index Trust F Dist | 22.42K | -6.90 | 11.55 | 13.45 | ||
Legal General US Index Trust I Acc | 1.53B | -6.78 | 11.83 | 13.73 | ||
Legal General US Index Trust I Dist | 1.6B | -6.81 | 11.82 | 13.72 | ||
Legal General US Index Trust C Dist | 929.38M | -9.51 | 8.16 | 13.29 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review